Annexon, Inc. (ANNX)
3.92
-0.05
(-1.26%)
USD |
NASDAQ |
Nov 13, 16:00
3.93
+0.01
(+0.26%)
After-Hours: 19:59
Annexon Total Assets (Quarterly) : 250.41M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 250.41M |
| June 30, 2026 | 246.07M |
| March 31, 2026 | 262.89M |
| December 31, 2025 | 277.57M |
| September 30, 2025 | 229.14M |
| June 30, 2025 | 264.57M |
| March 31, 2025 | 303.03M |
| December 31, 2024 | 350.07M |
| September 30, 2024 | 378.78M |
| June 30, 2024 | 406.08M |
| March 31, 2024 | 304.07M |
| December 31, 2023 | 297.67M |
| September 30, 2023 | 203.82M |
| June 30, 2023 | 233.01M |
| March 31, 2023 | 268.78M |
| December 31, 2022 | 285.10M |
| Date | Value |
|---|---|
| September 30, 2022 | 312.72M |
| June 30, 2022 | 220.70M |
| March 31, 2022 | 250.57M |
| December 31, 2021 | 287.04M |
| September 30, 2021 | 310.16M |
| June 30, 2021 | 331.78M |
| March 31, 2021 | 333.12M |
| December 31, 2020 | 355.95M |
| September 30, 2020 | 375.61M |
| June 30, 2020 | 131.09M |
| March 31, 2020 | 39.51M |
| December 31, 2019 | 49.90M |
| September 30, 2019 | 58.60M |
| June 30, 2019 | 35.72M |
| March 31, 2019 | |
| December 31, 2018 | 48.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 107.61M |
| Shareholders Equity (Quarterly) | 142.80M |
| Debt to Equity Ratio | 0.5126 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -1.13% |